4//SEC Filing
DeSilva Nishan M 4
Accession 0001453687-23-000086
CIK 0001453687other
Filed
Nov 14, 7:00 PM ET
Accepted
Nov 15, 5:18 PM ET
Size
9.9 KB
Accession
0001453687-23-000086
Insider Transaction Report
Form 4
DeSilva Nishan M
Director
Transactions
- Disposition to Issuer
Stock Option (Right to Buy)
2023-11-13−80,000→ 0 totalExercise: $4.57Exp: 2031-06-22→ Common Stock (80,000 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2023-11-13−40,000→ 0 totalExercise: $3.31Exp: 2032-01-02→ Common Stock (40,000 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2023-11-13$0.93/sh−75,000$69,750→ 0 totalExercise: $1.13Exp: 2033-01-01→ Common Stock (75,000 underlying)
Footnotes (3)
- [F1]This option, which provided for vesting in thirty-six (36) substantially equal monthly installments over three years following the date of grant on June 23, 2021, was canceled in the merger (the "Merger") between Selecta Biosciences, Inc. and Cartesian Therapeutics, Inc.
- [F2]This option, which provided for vesting in full on January 3, 2023, was canceled in the Merger.
- [F3]This option, which provided for vesting in full on January 2, 2024, was canceled in the Merger in exchange for a cash payment of $69,750, representing the difference between the exercise price of the option and $2.06, the Cash-out Amount as applied in the Merger.
Documents
Issuer
Cartesian Therapeutics, Inc.
CIK 0001453687
Entity typeother
Related Parties
1- filerCIK 0001492386
Filing Metadata
- Form type
- 4
- Filed
- Nov 14, 7:00 PM ET
- Accepted
- Nov 15, 5:18 PM ET
- Size
- 9.9 KB